TY - JOUR
T1 - Impact of Social Support on Colorectal Cancer Screening among Adult Hispanics/Latinos
T2 - A Randomized Community-based Study in Central Pennsylvania
AU - Dominic, Oralia G.
AU - Chinchilli, Vern
AU - Wasserman, Emily
AU - Curry, William J.
AU - Kambic, Daniel M.
AU - Caicedo, Christian H.
AU - Ramirez, Amelie G.
AU - Ochoa, John A.
AU - Lengerich, Eugene J.
N1 - Funding Information:
E. Wasserman reports grants from NIH NCATS UL1 TR002014 and grants from NIH during the conduct of the study. D.M. Kambic reports grants from NIH during the conduct of the study. C.H. Caicedo reports grants from NIH during the conduct of the study. No potential conflicts of interest were disclosed by the other authors.
Funding Information:
This work is supported by NIH NCI CRCHD K01 CA151752-02. The authors would like to thank the ACCN and also express their gratitude to Drs. Mark Dignan, Electra Paskett, Jill P. Smith, Robert A. Gabbay, Rhonda M. Johnson, Donald Fischer, and Alan Russell for their ongoing support and mentoring of young investigators, particularly Dr. Oralia Dominic. The authors acknowledge the assistance of the Penn State Clinical and Translational Science Institute (CTSI), the Northern Appalachia Cancer Network (NACN), and the Community Sciences and Health Outcomes Core of the PSCI in this research. Thanks also to the individuals that provided research staff support or technical support: Dr. Linda Wray at BBH-PSU; Edwin A. Diaz at Quest Diagnostics; and the partnered CBOs study sites that provided study advertisement efforts: Dr. Thomas P. Loughran Jr., Dr. Megan Mendez Miller, Dr. Raffy Luquis, Dr. Betsy Aumiller, Dr. Brenda Kluhsman, Fabian Camacho, Marcyann Bencivenga, Nancy Gallant Porter, Samantha DeVizio, Sol Colon-Rodriguez, Rafael DeJesus, Nichole Krebs, Dr. Ben Cocchiaro, David Fischer, Mauricio Conde, Carlos and Lydia Renderos, Jorge and Tatyana Flores De Valgaz, Dr. Hector Ortiz and Marisol Aviles de Ortiz, Fr. Bateman, Fr. Kevin Thompson, Fr. John Bednard, Fr. Orlando Reyes, Ruth Cruz, Jesus DeJesus, Mo, Norman Bristol Colon, Mildred Hernandez, Kelly Rodriguez, Major Moises Rivera, Leticia, Esmeralda Hetrick, Carlos Lopez, Evita Cotta, Carol Fagan, Lorna LeMelle, Meagan LeMelle, Norleen Duncan, Pastor Santiago and Maggie Roque, SACA, Carlos Graupera, Sandra Valdez, Noel Soto, Pedro and Lena Gratacos, Pastor Joseph L. Green, Ingrid Gonzalez, Edgar Castanon, Jeannine Peterson, Regina King, Kathy Lacomba, and Norma Miranda-Laboy.
Funding Information:
This work is supported by NIH NCI CRCHD K01 CA151752-02. The authors would like to thank the ACCN and also express their gratitude to Drs. Mark Dignan, Electra Paskett, Jill P. Smith, Robert A. Gabbay, Rhonda M. Johnson, Donald Fischer, and Alan Russell for their ongoing support and mentoring of young investigators, particularly Dr. Oralia Dominic. The authors acknowledge the assistance of the Penn State Clinical and Translational Science Institute (CTSI), the Northern Appalachia Cancer Network (NACN), and the Community Sciences and Health Outcomes Core of the PSCI in this research. Thanks also to the individuals that provided research staff support or technical support: Dr. Linda Wray at BBH-PSU; Edwin A. Diaz at Quest Diagnostics; and the partnered CBOs study sites that provided study advertisement efforts: Dr. Thomas P. Loughran Jr., Dr. Megan Mendez Miller, Dr. Raffy Luquis, Dr. Betsy Aumiller, Dr. Brenda Kluhsman, Fabian Camacho, Marcyann Bencivenga, Nancy Gallant Porter, Samantha DeVizio, Sol Colon-Rodriguez, Rafael DeJesus, Nichole Krebs, Dr. Ben Cocchiaro, David Fischer, Mauricio Conde, Carlos and Lydia Renderos, Jorge and Tatyana Flores De Valgaz, Dr. Hector Ortiz and Marisol Aviles de Ortiz, Fr. Bateman, Fr. Kevin Thompson, Fr. John Bednard, Fr. Orlando Reyes, Ruth Cruz, Jesus DeJesus, Mo, Norman Bristol Colón, Mildred Hernandez, Kelly Rodriguez, Major Moises Rivera, Leticia, Esmeralda Hetrick, Carlos Lopez, Evita Cotta, Carol Fagan, Lorna LeMelle, Meagan LeMelle, Norleen Duncan, Pastor Santiago and Maggie Roque, SACA, Carlos Graupera, Sandra Valdez, Noel Soto, Pedro and Lena Gratacos, Pastor Joseph L. Green, Ingrid Gonzalez, Edgar Castanon, Jeannine Peterson, Regina King, Kathy Lacomba, and Norma Miranda-Laboy.
Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - In the United States, the five-year survival rate of colorectal cancer for Latinos is lower than it is for White, non-Latinos. Differences in survival are due, in part, to Latinos being diagnosed at a later stage. An ethnic gap in the use of colorectal cancer screening contributes to the difference in survival. We developed, implemented, and evaluated a targeted colorectal cancer screening intervention to increase colorectal cancer screening uptake by sex, ethnicity, and geography. We measured actual colorectal cancer screening uptake in both arms as a method to determine completion rates. We used a randomized, community-based, participatory design to test the impact of social support (intervention) on completion of a provider-recommended, take-home fecal immunochemical test (FIT) kit screening test among average-risk, urban, and rural Pennsylvania Latino adults age 50 and older not currently adherent to national colorectal cancer screening guidelines (n ¼ 264). Participants in each arm attended a community-based educational program offered at eight sites. Among the 264 participants, 154 (58%) returned a completed usable FIT kit screening test. A higher return rate was observed among participants in the social support arm (66.0%) compared with the control (47.2%). Participants in the social support arm were statistically significant 2.67 times as likely to return a completed FIT kit. Of these, 27 (17.5%) had a positive FIT kit screening test result. The results of this study suggest that social support is an effective method to increase colorectal cancer screening rates among Latinos. Future studies should examine dissemination and implementation of community-based strategies among Latinos that include social support.
AB - In the United States, the five-year survival rate of colorectal cancer for Latinos is lower than it is for White, non-Latinos. Differences in survival are due, in part, to Latinos being diagnosed at a later stage. An ethnic gap in the use of colorectal cancer screening contributes to the difference in survival. We developed, implemented, and evaluated a targeted colorectal cancer screening intervention to increase colorectal cancer screening uptake by sex, ethnicity, and geography. We measured actual colorectal cancer screening uptake in both arms as a method to determine completion rates. We used a randomized, community-based, participatory design to test the impact of social support (intervention) on completion of a provider-recommended, take-home fecal immunochemical test (FIT) kit screening test among average-risk, urban, and rural Pennsylvania Latino adults age 50 and older not currently adherent to national colorectal cancer screening guidelines (n ¼ 264). Participants in each arm attended a community-based educational program offered at eight sites. Among the 264 participants, 154 (58%) returned a completed usable FIT kit screening test. A higher return rate was observed among participants in the social support arm (66.0%) compared with the control (47.2%). Participants in the social support arm were statistically significant 2.67 times as likely to return a completed FIT kit. Of these, 27 (17.5%) had a positive FIT kit screening test result. The results of this study suggest that social support is an effective method to increase colorectal cancer screening rates among Latinos. Future studies should examine dissemination and implementation of community-based strategies among Latinos that include social support.
UR - http://www.scopus.com/inward/record.url?scp=85085905344&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085905344&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-19-0333
DO - 10.1158/1940-6207.CAPR-19-0333
M3 - Article
C2 - 32127350
AN - SCOPUS:85085905344
SN - 1940-6207
VL - 13
SP - 531
EP - 542
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 6
ER -